From Financial Modeling Prep: 2025-05-19 11:00:00

In summary, Geron Corporation has a negative ROIC, while Stem, Inc. shows even lower capital efficiency. Agenus Inc. and Exelixis, Inc. demonstrate high capital efficiency, with Agenus standing out for its exceptionally high ROIC. Investors may want to consider these factors when evaluating investment opportunities in the biopharmaceutical industry.



Read more at Financial Modeling Prep:: Geron Corporation’s Capital Efficiency in the Biop…